These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36760155)

  • 1. Pharmacogenetic actionability and medication prescribing in people with cystic fibrosis.
    Anderson JD; Davis BH; Giang G; Jones A; Lee CR; Parker K; Searcy H; Benner K; Limdi NA; Guimbellot JS
    Clin Transl Sci; 2023 Apr; 16(4):662-672. PubMed ID: 36760155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opportunity for pharmacogenomic testing in patients with cystic fibrosis.
    Sakon C; Alicea LA; Patacca H; Brown CD; Skaar TC; Tillman EM
    Pediatr Pulmonol; 2022 Apr; 57(4):903-907. PubMed ID: 34967155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the frequency and the impact of pharmacogenetic alleles in an ancestrally diverse Biobank population.
    Verma SS; Keat K; Li B; Hoffecker G; Risman M; ; Sangkuhl K; Whirl-Carrillo M; Dudek S; Verma A; Klein TE; Ritchie MD; Tuteja S
    J Transl Med; 2022 Nov; 20(1):550. PubMed ID: 36443877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenomics: a tool to improve medication safety and efficacy in patients with cystic fibrosis.
    Sakon CM; Tillman EM
    Pharmacogenomics; 2022 Jun; 23(9):559-556. PubMed ID: 35670256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of population-level pharmacogenetic actionability in Alabama.
    Davis BH; Williams K; Absher D; Korf B; Limdi NA
    Clin Transl Sci; 2021 Nov; 14(6):2327-2338. PubMed ID: 34121327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of FDA Table of Pharmacogenetic Associations and Clinical Pharmacogenetics Implementation Consortium guidelines.
    Pritchard D; Patel JN; Stephens LE; McLeod HL
    Am J Health Syst Pharm; 2022 Jun; 79(12):993-1005. PubMed ID: 35230418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescription Patterns and Relationship to Pharmacogenomics Testing in the Military Health System.
    Selig DJ; Livezey JR; Chin GC; DeLuca JP; Guillory Ii WO; Kress AT; Oliver TO; Por ED
    Mil Med; 2021 Dec; 187(Suppl 1):9-17. PubMed ID: 34967405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for ivacaftor therapy in the context of CFTR genotype.
    Clancy JP; Johnson SG; Yee SW; McDonagh EM; Caudle KE; Klein TE; Cannavo M; Giacomini KM;
    Clin Pharmacol Ther; 2014 Jun; 95(6):592-7. PubMed ID: 24598717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence and resources to implement pharmacogenetic knowledge for precision medicine.
    Caudle KE; Gammal RS; Whirl-Carrillo M; Hoffman JM; Relling MV; Klein TE
    Am J Health Syst Pharm; 2016 Dec; 73(23):1977-1985. PubMed ID: 27864205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opportunity for Genotype-Guided Prescribing Among Adult Patients in 11 US Health Systems.
    Hicks JK; El Rouby N; Ong HH; Schildcrout JS; Ramsey LB; Shi Y; Anne Tang L; Aquilante CL; Beitelshees AL; Blake KV; Cimino JJ; Davis BH; Empey PE; Kao DP; Lemkin DL; Limdi NA; P Lipori G; Rosenman MB; Skaar TC; Teal E; Tuteja S; Wiley LK; Williams H; Winterstein AG; Van Driest SL; Cavallari LH; Peterson JF;
    Clin Pharmacol Ther; 2021 Jul; 110(1):179-188. PubMed ID: 33428770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential of pharmacogenetics in minimizing drug therapy problems in cystic fibrosis.
    Chhibber A; Watanabe AH; Jacobs H; Kharat A; Syeed SM; Sherwin CM; Chaiyakunapruk N; Biskupiak J; Yellepeddi VK; Brixner D; Young DC
    J Cyst Fibros; 2024 Jun; ():. PubMed ID: 38937211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescribing Prevalence of Medications With Potential Genotype-Guided Dosing in Pediatric Patients.
    Ramsey LB; Ong HH; Schildcrout JS; Shi Y; Tang LA; Hicks JK; El Rouby N; Cavallari LH; Tuteja S; Aquilante CL; Beitelshees AL; Lemkin DL; Blake KV; Williams H; Cimino JJ; Davis BH; Limdi NA; Empey PE; Horvat CM; Kao DP; Lipori GP; Rosenman MB; Skaar TC; Teal E; Winterstein AG; Owusu Obeng A; Salyakina D; Gupta A; Gruber J; McCafferty-Fernandez J; Bishop JR; Rivers Z; Benner A; Tamraz B; Long-Boyle J; Peterson JF; Van Driest SL;
    JAMA Netw Open; 2020 Dec; 3(12):e2029411. PubMed ID: 33315113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenomic potential in advanced cancer patients.
    Nichols D; Arnold S; Weiss HL; Wu J; Durbin EB; Miller R; Kolesar J
    Am J Health Syst Pharm; 2019 Mar; 76(7):415-423. PubMed ID: 31361818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescription medications with actionable pharmacogenomic recommendations in Veterans Health Administration patients.
    Maghari S; Gallo T; Rivas S; German A; Nguyen Le MQ; Abbaszadegan H; Zubriski MA; Heise CW; Landas ND
    Pharmacogenomics; 2023 Jun; 24(9):501-508. PubMed ID: 37435738
    [No Abstract]   [Full Text] [Related]  

  • 15. Variability Between Clinical Pharmacogenetics Implementation Consortium (CPIC
    Blazy C; Ellingrod V; Ward K
    Front Pharmacol; 2022; 13():939313. PubMed ID: 35814245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr; 46(4):352-372. PubMed ID: 36990700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetic Testing for the Pediatric Gastroenterologist: Actionable Drug-Gene Pairs to Know.
    Sandritter T; Chevalier R; Abt R; Shakhnovich V
    Pharmaceuticals (Basel); 2023 Jun; 16(6):. PubMed ID: 37375836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetics Guidelines: Overview and Comparison of the DPWG, CPIC, CPNDS, and RNPGx Guidelines.
    Abdullah-Koolmees H; van Keulen AM; Nijenhuis M; Deneer VHM
    Front Pharmacol; 2020; 11():595219. PubMed ID: 33568995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Practices in Pharmacogenomics.
    Ramsey LB; Prows CA; Tang Girdwood S; Van Driest S
    Pediatr Clin North Am; 2023 Oct; 70(5):995-1011. PubMed ID: 37704356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barriers to Implementing Clinical Pharmacogenetics Testing in Sub-Saharan Africa. A Critical Review.
    B Tata E; A Ambele M; S Pepper M
    Pharmaceutics; 2020 Aug; 12(9):. PubMed ID: 32858798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.